ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibroblasts"

  • Abstract Number: 2560 • 2013 ACR/ARHP Annual Meeting

    Analysis Of Global Gene Expression Of Pulmonary Endothelial Cells From Caveolin-1 Knock-Out Mice

    Sonsoles Piera-Velazquez1, Zhaodong Li1, Sankar Addya2, Peter J. Wermuth1 and Sergio A. Jimenez1, 1Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA, 2Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Caveolin-1 (Cav-1) deficiency has recently been shown to participate in the pathogenesis of tissue fibrosis in Systemic Sclerosis (SSc). Although the mechanisms involved have…
  • Abstract Number: 2568 • 2013 ACR/ARHP Annual Meeting

    Involvement Of Collagen-Binding Heat Shock Protein 47 In The Scleroderma-Associated Fibrosis

    Haiyan Chu1, Ting Wu1, Wenyu Wu2, Wenzhen Tu3, Yanyun Ma1, Qingmei Liu1, Hejian Zou4, Li Jin1 and Jiu-Cun Wang1, 1Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China, 2Division of Dermatology, Division of Dermatology, Huashan Hospital, Fudan University, Shanghai, Shanghai, China, 3Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shang hai, China, 4Rheumatology, Huashan Hospital, Shanghai, China

    Background/Purpose: Scleroderma or systemic sclerosis (SSc) is characterized by the fibrosis of skin and visceral organs, especially the uncontrolled fibrosis of multiple organs. Collagen is…
  • Abstract Number: 2418 • 2013 ACR/ARHP Annual Meeting

    The Transmembrane Protein Tyrosine Phosphatase Kappa Promotes Aggressiveness Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    Stephanie M. Stanford1, William B. Kiosses2, Amanda M. Campbell3, Michael F. Maestre3, David L. Boyle4, Gary S. Firestein4 and Nunzio Bottini3, 1Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2The Scripps Research Institute, La Jolla, CA, 3La Jolla Institute for Allergy and Immunology, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

    Background/Purpose: Fibroblast-like synoviocytes (FLS) in the synovial intimal lining are key mediators of inflammation and joint destruction in rheumatoid arthritis (RA). In RA these cells…
  • Abstract Number: 2231 • 2013 ACR/ARHP Annual Meeting

    The Actin-Crosslinking Protein Lasp-1 Regulates Synovial Fibroblast Migration and Cartilage Destruction In Arthritis

    Denise Beckmann1, Jan Hillen2, Marianne Heitzmann2, Catherine S. Chew3, Stefan Butz4, Dietmar Vestweber5, Hermann Pavenstädt6, Thomas Pap7 and Adelheid Korb-Pap2, 11nstitute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 2Institute of Experimental Muskuloskeletal Medicine, University Hospital Muenster, Muenster, Germany, 3Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, 4Max Planck Institute of Molecular Biomedicine, Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 5Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 6Internal Medicine D, Department of Nephrology and Rheumatology, University Hospital Muenster, Muenster, Germany, 7Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: Lasp-1 localizes at focal adhesions along stress fibres and leading edges of migrating cells and regulates the metastatic dissemination of tumors. Although rheumatoid arthritis…
  • Abstract Number: 2216 • 2013 ACR/ARHP Annual Meeting

    Tubastatin A, a Selective Histone Deacetylase-6 Inhibitor, Suppresses Synovial Inflammation and Joint Destruction In a Collagen Antibody-Induced Arthritis Mouse Model

    Joong Kyong Ahn1, Jaejoon Lee2, Hyemin Jeong2, Jiwon Hwang2, Seulkee Lee2, Ji Young Chai3, Inyoung Kim2,4, Eun Chung Hong5, Eun-Kyung Bae5, Hoon-Suk Cha2 and Eun-Mi Koh2, 1Department of Medicine, Kangbuk Samsung hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Division of Rheumatology, Jesang Hospital, Seongnam-si Gyeonggi-do, South Korea, 4MD, Seoul, South Korea, 5Samsung Biomedical Research Institute, Seoul, South Korea

    Background/Purpose: Histone deacetylases (HDAC) play a key role in regulating gene expression by deacetylasing histones, and HDAC inhibitors induce various cellular effects, including apoptosis, cell…
  • Abstract Number: 2227 • 2013 ACR/ARHP Annual Meeting

    The Anti-Proliferative Function of RSK2 in Synovial Fibroblasts Protects Against TNF-á-Induced Joint Destruction in Inflammatory Arthritis

    Anja Derer1, Christina Boehm1, Bettina Groetsch1, Michael Stock1, Kirsten Neubert2, Sybille Boehm3, Bettina Sehnert1, Georg Schett1, Axel J. Hueber4 and Jean-Pierre David5, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Clinical Research Group, Nikolaus-Fiebiger Center, University of Erlangen-Nuremberg, Erlangen, Germany, 3Institute of Genetics, Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 5Group Genes and Transcription, Institute of Osteology and Biomechanics (IOBM), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Background/Purpose: The pro-inflammatory cytokine Tumor Necrosis Factor alpha (TNF-α) directly activates the ribosomal S6 kinase RSK2 in vitro. We recently demonstrated the protective effect of…
  • Abstract Number: 1775 • 2012 ACR/ARHP Annual Meeting

    The Phosphoinositide 3-Kinase Pathway Regulates Fibroblast-Like Synoviocyte Invasion

    Beatrix Bartok1, Deepa Hammaker2 and Gary S. Firestein3, 1Rheumatology, UCSD, La Jolla, CA, 2MC 0656, Univ of California San Diego, La Jolla, CA, 3Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: Cartilage destruction mediated by invasive fibroblast-like synoviocytes (FLS) plays a central role in pathogenesis of RA. Increased cell migration and degradation of extracellular matrix…
  • Abstract Number: 1659 • 2012 ACR/ARHP Annual Meeting

    Ptpome Profile of Rheumatoid Arthritis Fibroblast-Like Synoviocytes: A Novel Role for the Tyrosine Phosphatase SHP-2 As a Modulator of Invasion and Survival

    Stephanie Stanford1, Michael Maestre2, Beatrix Bartok3, David L. Boyle4, Heather Arnett5, Tomas Mustelin6, Gary S. Firestein7 and Nunzio Bottini2, 1Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2La Jolla Institute for Allergy and Immunology, La Jolla, CA, 3Rheumatology, UCSD School of Medicine, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA, 5Amgen, Inc., Seattle, WA, 6Sanford-Burnham Institute for Medical Research, La Jolla, CA, 7Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: Fibroblast-like synoviocytes (FLS) in the synovial intimal lining are key mediators of inflammation and joint destruction in rheumatoid arthritis (RA). These cells assume a…
  • Abstract Number: 1610 • 2012 ACR/ARHP Annual Meeting

    The DNA Methylation Signature in Fibroblast-Like Synoviocytes (FLS) Defines Critical Pathogenic Pathways in Rheumatoid Arthritis (RA)

    David L. Boyle1, Robert Shoemaker2, David W. Anderson3, Wei Wang4 and Gary S. Firestein5, 1Div of Rheum, UCSD School of Medicine, La Jolla, CA, 2NexDx, Inc., San Diego, CA, 3Research and Development, NexDx, Inc., San Diego, CA, 4Chemistry, UCSD, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: A DNA methylation signature has been characterized that distinguishes RA FLS from osteoarthritis (OA) and normal (NL) FLS. The presence of epigenetic changes in…
  • Abstract Number: 1517 • 2012 ACR/ARHP Annual Meeting

    TLR9 Signaling in Fibroblasts Promotes Pro-Fibrotic Responses Via TGF-Beta

    Yang Yang1, Feng Fang2, Lei Liu1, Junjie Shangguan3, Boping Ye1 and John Varga3, 1School of Life Science and Technology, China Pharmaceutical University, Nanjing, China, 2Rheumatology Division, Northwestern University, Chicago, IL, 3Division of Rheumatology, Northwestern University, Chicago, IL

    Background/Purpose: Systemic sclerosis (SSc) is associated with progressive fibrosis and transforming growth factor β (TGF-β) is implicated in its pathogenesis. Toll-like receptors (TLR) respond to…
  • Abstract Number: 1499 • 2012 ACR/ARHP Annual Meeting

    The Soluble Guanylate Cyclase Mediates Its Anti-Fibrotic Effects by Inhibiting TGF-β Signaling

    Christian Beyer1, Sonia C. Schindler2, Alfiya Distler3, Clara Dees4, Helena Reichert2, Hümeyra Akan2, Peter Sandner5, Oliver Distler6, Georg Schett7 and Joerg HW Distler3, 1Department of Internal Medicine 3, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Bayer Health Care, Global Drug Discovery – Common Mechanism Research, Bayer Health Care, Global Drug Discovery – Common Mechanism Research, Wuppertal, Germany, 6Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 7Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: We have recently demonstrated that stimulation of the soluble guanylate cyclase (sGC) has potent anti-fibrotic activity in different models of fibrosis. sGC stimulation increases…
  • Abstract Number: 1500 • 2012 ACR/ARHP Annual Meeting

    Activation of Pregnane X Receptor Induces Regression of Experimental Dermal Fibrosis

    Christian Beyer1, Alla Skapenko2, Alfiya Distler3, Clara Dees4, Helena Reichert5, Louis E. Munoz3, Jan Leipe6, Hendrik Schulze-Koops7, Oliver Distler8, Georg Schett9 and Joerg HW Distler3, 1Department of Internal Medicine 3, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Division of Rheumatology and Clinical Immunology, Med. Poliklinik,, University of Munich, Munich, Germany, 3Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 6Med. Poliklinik, University of Munich, Division of Rheumatology and Clinical Immunology, Munich, Germany, 7University of Munich, Munich, Germany, 8Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 9Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: Pregnane-X-receptor (PXR) belongs to a superfamily of nuclear receptors that function as ligand-activated transcriptional factors. Although endogenous ligands have not yet been identified, PXR…
  • Abstract Number: 1505 • 2012 ACR/ARHP Annual Meeting

    Inactivation of Tankyrases Ameliorates Canonical Wnt Signaling and Prevents Experimental Fibrosis

    Alfiya Distler1, Lisa Deloch2, Jingang Huang2, Clara Dees2, Neng Yu Lin2, Christian Beyer3, Oliver Distler4, Georg A. Schett5 and Joerg HW Distler1, 1Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Internal Medicine 3, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 4Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 5Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: Systemic sclerosis (SSc) is characterized by aberrant activation of fibroblasts with increased release of extracellular matrix components. Canonical Wnt signaling has recently emerged as…
  • Abstract Number: 1492 • 2012 ACR/ARHP Annual Meeting

    IL-13 Receptors and Signaling in the Dermal Fibroblasts From Patients with Systemic Sclerosis

    Yuko Ota1, Yasushi Kawaguchi1, Atsushi Kitani2, Kae Takagi1, Hisae Ichida1, Yasuhiro Katsumata1, Takahisa Gono1, Masanori Hanaoka1, Yuko Okamoto1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Mucosal Immunity Section, NIAID/NIH, Bethesda, MD

    Background/Purpose: Interleukin (IL)-13 is a pleiotropic cytokine involved in T helper type 2 cell immune response and in the development of fibrotic conditions such as…
  • Abstract Number: 2309 • 2012 ACR/ARHP Annual Meeting

    Increased Levels of Ser 181 Phosphorylated SOX9 in SSc Dermal Fibroblasts: A Novel Participant in the Pathogenesis of SSc Fibrotic Process

    Sonsoles Piera-Velazquez, Jolanta Fertala and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: SOX9, a high mobility group (HMG) transcription factor is a master regulator of chondrogenesis and is essential for the maintenance of the chondrocyte-specific phenotype…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology